Simple night time airflow control device eases persistent asthma symptoms

November 24, 2011

A simple device that filters out airborne asthma triggers during sleep can ease persistent symptoms of the condition during the day and improve quality of life, suggests research published online in Thorax.

Temperature controlled laminar airflow treatment, or TLA for short, delivers a constant, slightly cooled airflow in the patient's breathing area, which displaces warmer air containing irritants and , such as house dust mite and pet hairs.

The aim is to stave off the abnormal that triggers a systemic allergic reaction, including the airway narrowing typical of an , by preventing the sleeper breathing in the irritants and allergens.

The authors base their findings on 281 non-smokers (either passive or active), aged between 7 and 70, from six European countries. All of them had poorly controlled atopic (allergic) asthma.

Of these, 189 slept with a TLA device (Protexo) just above their bed for a year. The remainder were given a dummy device.

A validated score was used to assess quality of life before and after the 12-month study period, in conjunction with assessments of symptom control, , , and biological indicators of a systemic .

The results showed a significant difference of 14-15% on quality of life scores between those using Protexo and those using the dummy device.

A steeper fall in nitric oxide - an indicator of inflammation - was seen among those using Protexo, and this was particularly noticeable among those with more severe asthma. Those using this device also had significantly smaller increases in another indicator of persistent and more severe inflammation - immunoglobulin E (IgE).

The impact was greatest among those whose asthma required the most medication yet whose symptoms were the most poorly controlled, a group who "represent a significant area of unmet need," say the authors.

Despite advances in the treatment of asthma, the condition is still very distressing for a significant proportion of patients, they explain. Previous attempts to filter or purify have not met with a great deal of success.

"The reason that nocturnal TLA is successful where so many other approaches have failed may be the profound reduction in inhaled aeroallergen exposure, which this treatment achieves," they suggest.

They point to other research suggesting that night time allergen exposure has the greatest impact on symptom severity, possibly because of changes in circulating hormone levels and immune responsiveness prompted by the body's internal clock (circadian rhythms).

Explore further: Researchers find herbal medicine treatment reduces inflammation in allergen-induced asthma

Related Stories

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.